Conditional PDK1 Ablation Promotes Epidermal and T-Cell-Mediated Dysfunctions Leading to Inflammatory Skin Disease  by Yu, Minjun et al.
Conditional PDK1 Ablation Promotes Epidermal and
T-Cell-Mediated Dysfunctions Leading to
Inﬂammatory Skin Disease
Minjun Yu1,2, David M. Owens3,4, Sankar Ghosh5 and Donna L. Farber1,5,6
Phosphoinositide-dependent kinase-1 (PDK1) is a key signaling molecule downstream of the phosphatidylino-
sitol 3-kinase pathway and is a master regulator of multiple kinases in cells of epithelial and hematopoietic
lineages. The physiological role of PDK1 in regulating skin and immune homeostasis is not known. Here we
developed a mouse model in which PDK1 is conditionally ablated in activated CD4 T cells, regulatory T cells, and
mature keratinocytes through OX40-Cre recombinase expression. The resultant mice (PDK1-CKO) spontaneously
developed severe dermatitis, skin ﬁbrosis, and systemic T helper type 2 immunity, succumbing by 11 weeks of
age. Through a series of T-cell transfers, bone marrow reconstitutions, and crossing to lymphocyte-deﬁcient
backgrounds, we demonstrate that ablation of PDK1 in keratinocytes is the major driver of disease pathogenesis.
PDK1-deﬁcient keratinocytes exhibit intrinsic defects in the expression of key structural proteins including
cytokeratin-10 and loricrin, resulting in increased keratinocyte turnover, which in turn triggers inﬂammation,
T-cell recruitment, and immune-mediated destruction. Our results reveal PDK1 as a central regulator of
keratinocyte homeostasis that prevents skin immune inﬁltration and inﬂammation.
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INTRODUCTION
Inﬂammatory skin diseases such as atopic dermatitis and
psoriasis involve immune-mediated and skin-intrinsic defects,
with each disease having speciﬁc immune signatures and skin
pathology (Boguniewicz and Leung, 2011; Guttman-Yassky
et al., 2011; Bergboer et al., 2012; Quaranta et al., 2014).
Genome-wide association studies have identiﬁed genes
involved in skin barrier integrity and immune regulation
(Tsoi et al., 2012; Ellinghaus et al., 2013) to be associated with
inﬂammatory skin diseases; however, the respective role of
skin-intrinsic versus immune-mediated factors in disease
induction is not known. Mouse models targeting keratinocyte
signaling can lead to development of skin pathology and
immune activation, with features of human inﬂammatory skin
diseases (Sano et al., 2005; Zenz et al., 2005). Identifying new
targets by which keratinocytes interface with the immune
system is important for developing new therapies for these
complex diseases that have no cure.
Phosphoinositide-dependent kinase-1 (PDK1) is a key
signaling regulator downstream of the phosphatidylinositol
3-kinase pathway and signals upstream of multiple protein
kinases, including PKA, Akt, PKC, and p70S6 (Toker and
Newton, 2000; Mora et al., 2004). PDK1 is broadly expressed
in many cell types, including epithelial and hemato-
poietic lineages, and is important for embryonic develop-
ment, cell growth, survival, and metabolism (Mora et al.,
2003; Hashimoto et al., 2006; Chen et al., 2013). The
phosphatidylinositol 3-kinase/Akt/mammalian target of
rapamycin pathway promotes proliferation of epidermal
precursors (Murayama et al., 2007) and is implicated in skin
tumorigenesis (Segrelles et al., 2002; Suzuki et al., 2003),
although the physiological role of PDK1 in the skin is not
deﬁned. PDK1 is known to have central roles in immune
cells, as conditional PDK1 ablation in developing T cells
results in impaired function through the abrogation of
downstream PKCθ phosphorylation and NF-κB activation
(Park et al., 2009).
In this study, we identify PDK1 as a molecular regulator of
keratinocyte homeostasis and of the skin–immune interface
that when disrupted in vivo triggers severe skin pathology,
systemic inﬂammation, and morbidity. We generated a mouse
model with conditional ablation of PDK1 by OX40-directed
Cre expression resulting in simultaneous PDK1 deletion in
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subsets of activated and regulatory CD4 T cells and mature
keratinocytes. The resultant PDK1-CKO mice are born healthy
but gradually develop severe inﬂammatory skin disease,
with systemic T helper type 2 (Th2)-mediated inﬂammation,
skin thickening, and ﬁbrosis. We dissected the relative
contribution of PDK1-deﬁcient T cells and keratinocytes to
disease pathogenesis and demonstrate a dominant role for
PDK1-deﬁcient keratinocytes in driving disease through
dysregulation of keratinocyte differentiation and turnover.
Our results reveal that PDK1 signaling is a central regulatory
pathway for keratinocyte homeostasis that prevents patholo-
gical immune inﬁltration and skin inﬂammation.
RESULTS
Spontaneous dermatitis and skin ﬁbrosis in PDK1 conditional
knockout mice
We constructed a mouse model with conditional ablation of
PDK1 in activated CD4 T cells by crossing three mouse strains
(Supplementary Figure S1a online): (1) PDK1 ﬂox/ﬂox mice
(Mora et al., 2003) to (2) ROSA26-yellow ﬂuorescent protein
reporter mice (R26-YFP) (Srinivas et al., 2001) to (3) OX40-Cre
mice (Klinger et al., 2009), which restrict Cre expression to
activated CD4 T cells and a subset of regulatory T cells (Tregs)
(Redmond et al., 2009). The resultant OX40+/Cre PDK1F/F
R26-YFP mice, designated PDK1-CKO, express YFP in all
PDK1-ablated CD4 T cells, whereas the control strain (PDK1-
CHET) is heterozygous at the ﬂoxed PDK1 locus (OX40+/Cre
PDK1F/+ R26-YFP) and maintains PDK1 expression in YFP+
cells (Supplementary Figure S1b online).
PDK1-CKO mice were born healthy; however, starting at
5 weeks of age, they developed severe, systemic dermatitis
accompanied by hair loss and skin thickening (Figure 1a).
PDK1-CKO mice further developed peripheral lymphadeno-
pathy, an enlarged spleen (Figure 1a), and wasting syndrome,
succumbing to disease by 11 weeks of age, whereas PDK1-
CHET mice maintained normal health (Figure 1a and b).
The skin of PDK1-CKO mice contained multiple alterations
by histological anlaysis, including epidermal scales, hyper-
plasia, hyperkeratosis, loss of hair follicles, and hypodermal
fat, and increased dermal ﬁbrosis, whereas the skin of PDK1-
CHET mice remained healthy (Figure 1c and Supplementary
Table S1 online). The skin of PDK1-CKO mice with advanced
disease contained lesions with epidermal damage, resulting in
loss of skin barrier integrity, as shown by dye penetration
(Supplementary Figure S1c online). This skin barrier defect
was observed in mice with severe disease at 7–8 weeks of age
and not in infant mice (Supplementary Figure S1c online). We
did not observe inﬂammation in other organs (lung, liver,
kidney, and gut) (Supplementary Figure S1c online), indicat-
ing that the tissue target of disease pathology in PDK1-CKO
mice was limited to skin.
PDK1-CKO mice develop spontaneous Th2 responses and Treg
deﬁciency
OX40-directed PDK1 ablation resulted in alterations in
effector T-cell and Treg frequencies and function in PDK-
CKO mice. CD4 T cells isolated from diseased PDK1-CKO
mice exhibited an activated phenotype and higher proportion
of YFP+ cells compared with PDK1-CHET mice (Figure 1d).
Functionally, a signiﬁcant fraction of YFP+ CD4 T cells from
PDK1-CKO mice, but not from PDK1-CHET mice, produced
IL-4 (but not IFN-γ) following stimulation with anti-CD3/
anti-CD28 antibodies (Figure 1e and Supplementary
Figure S2a online). GATA3 staining conﬁrmed that YFP+
T cells were Th2 T cells, suggesting spontaneous differentia-
tion of Th2 effector cells in PDK1-CKO mice (Supplementary
Figure S2b online). A small fraction of YFP+ CD4 T cells
from PDK1-CKO mice, but not from PDK1-CHET mice, also
produced IL-17A after stimulation (Supplementary Figure S2c
online).
In diseased PDK1-CKO mice, the frequency of Foxp3+
CD25+ Tregs was signiﬁcantly decreased with a correspond-
ing increase in Foxp3−CD25+ effector T cells (Supplementary
Figure S3a online). To assess the role of Tregs in the disease
process, we transferred CD4+CD25+ Tregs from wild-type
mice into PDK1-CKO recipients (o4 weeks of age). Whereas
PDK-1-CKO recipients of wild-type Tregs exhibited improved
survival and reduced skin symptoms, morbidity and disease
score were only slightly reduced in Treg recipients, which
continued to exhibit skin pathology (Supplementary Figure
S3c and d online) despite reconstitution of Foxp3+ Tregs
(Supplementary Figure S3e online). Therefore, the reduced
Treg frequency in PDK-CKO mice is not a primary disease
trigger.
T-cell–intrinsic immune impairments in PDK1-CKO mice cause
mild skin disease
We assessed the role of aberrantly activated T cells from
PDK1-CKO mice in promoting disease development by
transfer of puriﬁed T cells from PDK1-CKO or -CHET mice
into lymphocyte-deﬁcient RAG2− /− recipients to generate
RAG2+CKO and RAG2+CHET recipient mice. RAG2+CKO
mice gradually developed skin lesions and hair loss in a
limited region, whereas RAG2+CHET mice remained healthy
(Figure 2a). Notably, the overall disease score of RAG2+CKO
mice was much lower compared with that of intact PDK1-
CKO donor mice (Figure 2b), with eight of the nine mice
surviving beyond 12 weeks posttransfer. Skin histology
revealed skin scale formation, hyperkeratosis, epidermal
hyperplasia, and ﬁbrosis (Figure 2c and Supplementary Table
S1 online). Moreover, YFP+ CD4 T cells inﬁltrated into the
dermal layer of RAG2+CKO but not of RAG2+CHET mice
(Figure 2d). These results indicate that pathogenic skin-homing
T cells develop in diseased PDK1-CKO mice; yet, these T cells
do not appear to be broadly autoreactive and do not promote
severe systemic morbidity manifested in PDK1-CKO mice.
Hematopoietic lineage cells from PDK1-CKO mice are not
sufﬁcient to trigger skin pathology
We asked whether hematopoietic lineage cells in PDK1-CKO
mice contributed to disease pathogenesis using bone marrow
(BM) reconstitutions. Lethally irradiated RAG2− /− mice were
reconstituted with T-cell-depleted BM from PDK1-CKO or
-CHET mice resulting in CKO-BMT (BM transfer) and CHET-
BMT mice, respectively. CKO-BMT mice did not exhibit
mortality but gradually developed weight loss and morbidity
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Figure 1. Conditional ablation of phosphoinositide-dependent kinase-1 (PDK1) in OX40-expressing cells results in diffuse dermatitis, ﬁbrosis, and Th2
polarization. (a) Macroscopic view of PDK1-CKO and PDK1-CHET mice (left), cervical lymph nodes (upper right), and spleen (lower right) from each strain.
(b) Survival curve of PDK1-CHET (n=20) and PDK1-CKO (n= 15) mice. (c) Skin sections from PDK1-CKO and PDK1-CHET mice showing hematoxylin and
eosin staining (upper row) and Masson Trichrome staining (lower row). Bars=100 μm (*Indicates epidermal hyperplasia). (d) Flow cytometric analysis of CD4
T cells from peripheral lymph nodes of PDK-CKO and PDK1-CHET mice (7–8 weeks old). Left: forward scatter versus side scatter; middle: yellow ﬂuorescent
protein (YFP) expression by CD4 T cells (shown as mean± s.e.m., n=6); right: CD44 versus CD62L expression of CD4+YFP+ cells. (e) IL-4 production from
PDK1-CKO CD4 T cells expressed as percentage of YFP+IL-4+ in each quadrant drawn based on control unstimulated T cells.
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Figure 2. Phosphoinositide-dependent kinase-1 (PDK1)-deﬁcient T cells promote skin pathology and mild disease in RAG2− /− hosts. (a) Macroscopic view of
RAG2− /− recipients 13 weeks posttransfer of 5× 106 CD3+ T cells from PDK1-CKO (“RAG2+CKO”, left) or PDK1-CHET (“RAG2+CHET”, right) mice. (b) Disease
score (see Materials and Methods) of RAG2+CHET (n=5) or RAG2+CKO (n= 8) recipients of T cells 12 weeks posttransfer compared with the disease
score of 8-week-old PDK1-CKO parental mice. (c) Skin sections of RAG2+CKO and RAG2+CHET recipient mice stained with hematoxylin and eosin (upper)
or Masson Trichrome (lower). Bars= 100 μm. (d) Immunoﬂuorescence of CD4 (ﬁrst column) and yellow ﬂuorescent protein (YFP; second column) expression
together with DAPI (4,6-diamidino-2-phenylindole) nuclear staining (third column) in skin sections from RAG2+CKO (upper row) and RAG2+CHET (lower row)
mice. Bars=25 μm. D, dermis; ED, epidermis.
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12 weeks post-BMT coincident with reduced Treg levels,
whereas CHET-BMT mice did not develop disease and had
normal Treg levels (Supplementary Figure S4a online).
Notably, skin symptoms in CKO-BMT mice were only
sporadically observed with no overt hair loss, dermatitis, or
epidermal hyperplasia, nor was there inﬁltration of YFP+
CD4+ T cells into the skin (Supplementary Figure S4c and
Supplementary Table S1 online). These BMT results indicate
that the T-cell-intrinsic impairments were not responsible for
the severe skin disease and development of pathogenic skin-
homing T cells observed in parent PDK1-CKO mice and
suggest that a non-hematopoietic cell may promote skin
disease pathogenesis.
OX40-Cre-mediated PDK1 ablation targets mature
keratinocytes
OX40-directed gene ablation has been associated with
potential manifestations in the skin (Cornish et al., 2012).
During our analyses, we observed YFP expression not only in
CD4+ T cells but also in the epidermis of both PDK1-CKO
and -CHET mice (Figure 3a). Notably, sorted YFP+ cells
residing in the epidermis of PDK1-CKO mice exhibited greatly
reduced PDK1 transcript expression compared with YFP+
cells in PDK1-CHET skin (Figure 3a, right). These results also
suggested that OX40 is expressed in YFP+ skin cells, which
we conﬁrmed by OX40-quantitative PCR of sorted YFP+
epidermal cells from PDK1-CKO and -CHET mice but not in
YFP+ cells from homozygous OX40Cre/Cre ROSA-YFP mice
that lack OX40 expression because of Cre insertion (Klinger
et al., 2009) (Figure 3b). OX40 expression was mostly
localized to basal layer keratinocytes (deﬁned by keratin-14
(krt14) expression) by immunoﬂuorescence (Supplementary
Figure S5a online). Together, these results demonstrate
speciﬁc ablation of PDK1 in basal keratinocytes of
PDK1-CKO mice through OX40-dependent Cre expression.
We investigated whether PDK1 ablation in epidermal cells
affected its turnover. The basal epidermal layer of PDK1-CKO
mice exhibited Ki67 staining compared with PDK1-CHET
mice (Figure 3c), indicative of hyperproliferation. Because
disease manifestations in PDK1-CKO mice occurred only at
5–7 weeks of age, we hypothesized that the timing of YFP
expression/PDK1 ablation may occur in mature keratinocytes
and not in the developing mouse skin. Interestingly, YFP was
only sporadically expressed in the epidermis of mice at
10 days and 3 weeks of age, and was highly expressed only in
adult mice at 6 weeks of age when signiﬁcant CD4+YFP+
T cells had also inﬁltrated the skin (Figure 3d). Correspond-
ingly, mild epidermal hyperplasia and microabscess were
observed in mice at 3 weeks of age but not at 10 days
(Supplementary Figure S5b online), showing that PDK1
ablation in keratinocytes is coincident with disease
development.
Lymphocyte-deﬁcient PDK1-CKO mice develop skin pathology
To dissect the contribution of the skin-intrinsic defects in
PDK1-CKO mice, we generated lymphocyte-deﬁcient
CKO×RAG2− /− (and control CKO×RAG2+/− ) mice by
interbreeding. These mice also exhibited skin-speciﬁc YFP
expression and PDK1 ablation, which were both largely
conﬁned to α6-integrin+ basal keratinocytes (Supplementary
Figure S6 online). Compared with control CKO×RAG2+/−
mice, which exhibited morbidity and skin disease similar to
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Figure 3. OX40-Cre-mediated phosphoinositide-dependent kinase-1 (PDK1) ablation occurs in epidermal cells of PDK1-CKO mice. (a) Left, Immuno-
ﬂuorescence of CD4 and yellow ﬂuorescent protein (YFP) expression with DAPI (4,6-diamidino-2-phenylindole) nuclear stain in the skin of PDK1-CKO mice
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the parent PDK1-CKO line, CKO×RAG2− /− mice developed
only a mild skin dermatitis with reduced morbidity (Figure 4a
and b). The mice survived longer than parent PDK-CKO mice
but eventually succumbed to disease at 12–16 weeks
(Figure 4c). There was inﬂammation in the skin of CKO×
RAG2− /− mice but reduced epidermal hyperplasia and
ﬁbrosis compared with CKO×RAG2+/− skin (Figure 4a).
However, extensive Ki67 expression was still observed in the
basal layer of CKO×RAG2− /− skin (Figure 4d), indicating that
epidermal hyperplasia observed in the parent PDK1-CKO
strain is due to a skin-intrinsic defect. This increased turnover
of PDK1-deﬁcient keratinocytes was not associated with overt
cell death, based on lack of cleaved Caspase3 staining
(Supplementary Figure S7 online). Together, these results
reveal a role for PDK1 in keratinocyte function and integrity,
and show that PDK1-deﬁcient keratinocytes can initiate
disease development.
PDK1 ablation in keratinocytes impairs differentiation and
promotes inﬂammation
We investigated whether PDK1 ablation in the epidermis
affected its function and integrity and/or was associated with
structural defects observed in atopic dermatitis and psoriasis
(Roberson and Bowcock, 2010; Boguniewicz and Leung,
2011). Expression of important structural proteins, including
keratin-10 (krt10), loricrin, and krt14, was signiﬁcantly
impaired in the skin of PDK1-CKO mice compared with
PDK1-CHET mice, as assessed by immunohistochemistry and/
or quantitative reverse-transcriptase–PCR (Figure 5a). By
contrast, other structural proteins, including krt14, keratin-1
(krt1), ﬁlaggrin, and involucrin, were comparably expressed
in the PDK1-CKO and -CHET skin (Supplementary Figure S8
online). Krt10 and loricrin expression was also reduced in
CKO×RAG2− /− skin (Figure 5b), indicating that PDK1
ablation in keratinocytes directly impacts keratinocyte differ-
entiation. Interestingly, expression of thymic stromal lympho-
poietin (TSLP), an inﬂammatory mediator, was speciﬁcally
upregulated in the epidermis of PDK1-CKO mice (but not
in control PDK1-CHET skin) by immunoﬂuorescence
(Figure 5c). TSLP was speciﬁcally expressed by sorted YFP+
keratinocytes of PDK-CKO (but not of PDK1-CHET) mice and
also by YFP+α6+ keratinocytes of CKO×RAG2− /− (but not of
CHET×RAG2− /−) mice (Figure 5d). Signiﬁcant levels of TSLP
were also detected in the serum of both PDK1-CKO and
CKO×RAG2− /− but not PDK1-CHET mice (Figure 5e).
Together, these results establish that PDK1-ablated keratino-
cytes produce TSLP.
PDK1 ablation in keratinocytes is sufﬁcient for inducing skin
inﬁltration and Th2 activation
In order to assess the role of PDK1− /− keratinocytes
in promoting disease in the context of a normal T-cell
response, we transferred T cells from PDK1-CHET mice into
CKO×RAG2− /− mice (with PDK1-ablated keratinocytes) or
CHET×RAG2− /− mice with intact keratinocytes and assessed
disease outcome. Transfer of (CHET) T cells into CKO×
RAG2− /− hosts signiﬁcantly exacerbated disease, including a
higher overall disease score and severe skin pathology,
including focal abscesses and ulcers (Figure 6a and b),
whereas T-cell transfers into CHET×RAG2− /− hosts caused
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no disease. Moreover, CHET-derived CD4+YFP+ T cells
inﬁltrated into the skin of CKO×RAG2− /− mice but not of
CHET×RAG2− /− mice (Figure 6c). Importantly, CHET T cells
that recovered from CKO×RAG2− /− hosts with the aberrant
skin phenotype produced IL-4 after stimulation, whereas
those that recovered from CHET×RAG2− /− recipients with
intact skin produced negligible IL-4 (Figure 6d). Together,
these results indicate that the altered skin environment
induced by PDK1 ablation in keratinocytes is the primary
driver of altered Th2 differentiation and skin-speciﬁc T-cell
homing that exacerbates and perpetuates disease.
DISCUSSION
We present here a model of inﬂammatory skin disease with
systemic inﬂammation and morbidity in mice with condi-
tional ablation of the PDK1 kinase (PDK1-CKO) in activated/
regulatory T-cell subsets and in mature keratinocytes.
Through a series of T-cell transfers, BM reconstitutions, and
crossing to lymphocyte-deﬁcient backgrounds, we demon-
strate that ablation of PDK1 in keratinocytes initiates disease
pathogenesis that is further exacerbated by T-cell-mediated
immune responses. We therefore deﬁne a role for PDK1 in
keratinocytes to maintain their homeostasis and prevent skin
inﬂammation and a model for studying complex pathogenesis
of inﬂammatory skin diseases.
Inﬂammatory skin disease is caused by the interplay of skin
barrier disruption and immune dysregulation. PDK1-CKO
mice had triple defects in conventional effector/memory
CD4 T cells, Tregs, and keratinocytes. We used a series of
T-cell transfers, BM reconstitutions, and crossings to
lymphocyte-deﬁcient backgrounds to identify the respective
roles of PDK1 ablation in each cell type. PDK1 ablation in
PDK1-CKO mice resulted in reduced Tregs, which is
consistent with previous ﬁndings that PDK1 is required for
Treg function (Park et al., 2010). However, PDK1-ablated
CD4 T cells (both conventional effector/memory CD4 T cells
and Tregs) in the context of healthy skin (in BMT) caused mild
morbidity, few skin symptoms, and no T-cell inﬁltration into
the skin (Supplementary Figure S4 online). Conversely,
transferring wild-type Tregs into PDK1-CKO mice did not
prevent disease induction, which indicates that impaired
Tregs were not the primary initiating factor of disease. Thus
immune-mediated defects appear secondary to disease
initiation.
We demonstrate that PDK1 ablation in keratinocytes was
sufﬁcient to trigger skin pathology and drive inﬂammatory
disease. PDK1 ablation in keratinocytes in the absence of
lymphocytes (CKO×RAG2− /−) exhibited similar defects in
the expression of keratinocyte structural proteins, epidermal
hyperplasia, and skin pathology as in the parent PDK1-CKO
PDK1-CKO PDK1-CHET
PDK1-CKO
PDK1-CHET
PDK1-CKO
PDK1-CHET
PDK1-
CHET
PDK1-CKO
PDK1-
CKO
PDK1-CHET
ED
ED
ED
ED ED
ED
ED ED
ED
ED
ED
Krt10
DAPI
DAPI DAPI
Krt10
DAPI
Krt10
DAPI
Krt10
DAPID
D
D D
D
D D
D
D
D
Loricrin Loricrin
DAPI
Loricrin
DAPI
Loricrin
TSLP
TSLP TSLP
TSLP
YFP YFP
Loricrin
1.5
1
0.5
0R
el
at
ive
 q
ua
nt
ity
R
el
at
ive
 q
ua
nt
ity
***
***
***
***
CKOXRAG2–/–
CKOX
RAG2–/–
CHETXRAG2–/–
CKOxRAG2–/–
CHETxRAG2–/–
30
20
10
0
30
20
10
0
Se
ru
m
 T
SL
P 
(pg
 m
l–1
) 800
600
400
200
0
NS
a
c
b
d e
Figure 5. Phosphoinositide-dependent kinase-1 (PDK1) ablation in skin impairs keratinocyte differentiation and increases inﬂammation. (a) Left,
Immunoﬂuorescence staining of keratin-10 (upper) and loricrin (lower) in skin sections from PDK1-CKO and PDK1-CHET mice. Bars=25 μm. Right, quantitative
PCR (qPCR) of loricrin expression (average of triplicates) in sorted YFP+ epidermal cells. (b) Immunoﬂuorescence of keratin-10 (upper) and loricrin (lower)
staining in skin sections from CKO×RAG2− /− and CHET×RAG2− /− mice. Bars=50 μm. (c) Left, Immunoﬂuorescence of yellow ﬂuorescent protein (YFP)
and thymic stromal lymphopoietin (TSLP) expression in the skin of PDK1-CKO mice and PDK1-CHET mice (7 weeks old). Bar= 25 μm. (d) TSLP transcript
expression level (qPCR, average of triplicates) in sorted YFP+ epidermal cells of PDK1-CKO and -CHET mice (upper) and YFP+α6-integrin+ cells of
CKO×RAG2− /− and CHET×RAG2− /− skin (lower). (e) Serum TSLP level from 6–8-week-old mice as indicated. *** represents Po0.001. NS, not signiﬁcant.
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mice (Supplementary Table S1 online). Moreover, PDK1-
deﬁcient keratinocytes in the context of normal T cells
developed severe dermatitis similar to the PDK1-CKO mice
(Figure 6, Supplementary Table S1 online). These results
indicate that PDK1-ablated keratinocytes can initiate disease
in the context of a normal immune system. Importantly,
PDK1-deﬁcient keratinocytes produced the pro-inﬂammatory
cytokine TSLP (Figure 5), known to promote Th2 responses.
PDK1 ablation in keratinocytes therefore disrupts the struc-
tural integrity of the skin, which in turn promotes inﬂamma-
tion, Th2 differentiation, and inﬁltration, setting up a cascade
of tissue damage, inﬂammation-induced acanthosis, and
ﬁbrosis.
Our results reveal a role for PDK1 in maintaining
keratinocyte function and integrity. Skin-speciﬁc gene abla-
tion in PDK1-CKO mice occurs because of OX40-mediated
Cre expression in keratinocytes, as observed in a previous
study (Cornish et al., 2012). On the basis of PDK1 function in
other types of cells, there are multiple pathways upstream of
PDK1 that could impact keratinocyte differentiation,
including Akt/mTOR and the canonical NF-κB pathway
(Tanaka et al., 2005; Park et al., 2010; Kang et al., 2013).
Akt signaling in keratinocytes has been shown to induce
their differentiation and survival (Thrash et al., 2006;
O'Shaughnessy et al., 2009), and PDK1 effects on
keratinocyte turnover could be mediated through Akt.
Keratinocyte-speciﬁc ablation of the IκB kinase, IKK2, which
is required for NF-κB activation (Li et al., 1999, 2000),
resulted in psoriasis-like dermatitis, impaired expression of
loricrin and ﬁlaggrin, and upregulated expression of TNF-α
and triggered similar but milder skin symptoms compared
with PDK1-deﬁcient keratinocytes (Pasparakis et al., 2002;
Stratis et al., 2006; Cornish et al., 2012). We propose that
the severe skin phenotypes induced by PDK1 ablation in
keratinocytes may be due to dysregulation of multiple
pathways (e.g., Akt, NFκB) for which PDK1 serves as a
central upstream regulator.
The skin manifestations due to PDK1 ablation mimic
different features of human skin diseases, with epidermal
hyperplasia, reduced Krt10 and loricrin expression, barrier
defects, and skewed Th2 responses similar to atopic
dermatitis, parakeratosis, and thickening observed in psori-
asis, and skin ﬁbrosis and Th2 responses seen in scleroderma
(Chizzolini et al., 2011; Guttman-Yassky et al., 2011). The
models presented here that separate skin-intrinsic and
immune-mediated bases of complex skin phenotypes, as well
as their combined effects, can be of important clinical
relevance for designing targeted therapies for treating
inﬂammatory skin syndromes.
MATERIALS AND METHODS
Mice
PDK1F/F mice (Mora et al., 2003) were crossed with R26 ROSA YFP
mice (Jackson Laboratories, Bar Harbor, ME) to generate PDK1F/F
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Figure 6. Phosphoinositide-dependent kinase-1 (PDK1) ablation in keratinocytes is sufﬁcient for inducing skin inﬁltration and T helper type 2 activation. T cells
from PDK1-CHET mice were transferred to CHET×RAG2− /− or CKO×RAG2− /− recipients (see Materials and Methods), resulting in CHET×RAG2− /−+
CHET or CKO×RAG2− /−+CHET mice, respectively. (a) Disease score of recipient strains 2 weeks posttransfer for CHET×RAG2− /− (n=4) and CKO×RAG2− /−
(n= 5) mice, compared with disease score of age-matched CKOXRAG2− /− mice (n=5) without transferred T cells. (b) Skin sections (hematoxylin and eosin
stained) from CHET×RAG2− /−+CHET and CKO×RAG2− /−+CHET mice 2 weeks posttransfer. Bars: I–II, 100 μm; III–IV, 50 μm. (c) Immunoﬂuorescence
of CD4 and yellow ﬂuorescent protein (YFP) expression in the skin of the indicated strains. Bars=50 μm. (d) IL-4 production by T cells isolated from
CHET×RAG2− /−+CHET or CKO×RAG2− /−+CHET mice expressed as mean frequency± s.e.m. of CD4+YFP+ IL-4+ cells after 5-h stimulation.
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ROSA26 YFP mice, which were further crossed with OX40-Cre mice
(Jackson Laboratories) to generate PDK1-CKO mice (OX40+/
crePDK1F/FROSA26 YFP) and PDK1-CHET mice (OX40+/crePDK1F/
+ROSA26 YFP), respectively. PDK1-CKO×RAG2+/− and PDK1-
CHET×RAG2− /− mice were generated by crossing with RAG2− /−
mice (Taconic Farms, Germantown, NY). All mice were housed and
bred in speciﬁc pathogen-free conditions in the Animal Barrier
Facility at Columbia University. All animal experiments were
approved by the Institutional Animal Care and Use Committee of
Columbia University.
Flow cytometry
Fluorochrome-conjugated antibodies speciﬁc for CD4, CD8, CD25,
CD44, IFN-γ, and GATA3, CD62L, IL-2, IL-4, and forkhead box P3
(Foxp3) were purchased from BD Biosciences (San Jose, CA) and
eBiosciences (San Diego, CA). For nuclear staining, cells were ﬁxed
and permeabilized with FoxP3 ﬁxation/permeabilization buffer
(eBioscience) and stained with anti-Foxp3 or GATA3 antibody. Cells
were analyzed using the FACSCantoII or LSRII ﬂow cytometer (BD
Biosciences) and data were analyzed using the Flowjo software
(Treestar, Ashland, OR).
Histology
All hematoxylin and eosin and Masson trichome staining
studies were performed by the Pathology Core of Columbia
University.
Disease scoring
Disease was scored on the basis of four aspects: activity, weight, hair
loss, and skin condition: for activity, 0= normal; 1= hunched
position at rest; 2= hunched, mild resistance when handled; and
3= severely hunched, no resistance when handled; for weight,
0= normal; 1=o15% weight loss; 2= 15–30% weight loss; and
3=430% weight loss; for hair loss, 0= normal; 1=o10% hair loss;
2= 10–30% hair loss; and 3=430% hair loss; and for skin
condition, 0= normal; 1= red, no scales or crust; 2= light skin scales
and crusty appearance; 3=moderate skin scales and crusty
appearance; and 4= severe skin scales and crusty appearance, loss
of skin elasticity. The total disease score was the sum of four
individual attributes, with the maximum combined disease score
being 13.
Immunoﬂuorescence
Skin samples were ﬁxed in 4% paraformaldehyde, dehydrated in
30% sucrose, embedded in Optimal Cutting Temperature (OCT), and
frozen. Skin cryostat sections (5 mm) were stained with antibodies
speciﬁc for YFP (Life Technologies, Grand Island, NY), OX40 (BD
Biosciences), ﬁlaggrin (Santa Cruz, Dallas, TX), involucrin (Covance,
Princeton, NJ), loricrin, cytokeratin14, cytokeratin15, cytokeratin10
(Genetex, Irvine, CA) Ki67, CD4 (eBioscience), cleaved caspase 3
(Cell Signaling Technologies, Danvers, MA), and TSLP (R&D
Systems, Minneapolis, MN) and then stained with ﬂuorescently
coupled secondary anti-rabbit or anti-rat IgG (Cell Signaling) or with
streptavidin-conjugated Cy5 (Biolegend, San Diego, CA). Images
were obtained using the LAS AF 6.2 software on a motorized Leica
DMI 6000B ﬂuorescence microscope (Leica Microsystems GmbH,
Wetzlar, Germany).
T-cell transfer and BM reconstitution
T cells were puriﬁed from the spleen and peripheral lymph nodes of
PDK1-CKO and -CHET mice by anti-CD3ε microbeads (Miltenyi
Biotec, San Diego, CA). T cells (5× 106 per mouse) were transferred
to RAG2− /− recipients intravenously by tail vein injection. For BM
reconstitution experiments, BM mononuclear cells isolated from the
femurs and tibia of CD45.2 PDK1-CKO or -CHET mice were
depleted of CD3+ T cells using anti-CD3ε microbeads (Miltenyi
Biotec), and 5× 106 cells were transferred intravenously into CD45.1
RAG2− /− mice irradiated with 9 Gy by means of an RS2000
irradiator (Rad Source Tech, Suwanee, GA) 1 day previously.
T-cell stimulation and intracellular cytokine staining
CD4 T cells puriﬁed by negative selection (Stem Cell Tech,
Vancouver, BC, Canada) were activated with anti-CD3/CD28
antibodies (5 μgml−1/2.5 μg ml−1, BD Biosciences) in the presence
of 0.66 μl ml− 1 GolgiStop (BD Bioscences) for 5 hours, and cytokine
production was assessed by intracellular cytokine staining.
ELISA
Serum TSLP level was measured using the mouse TSLP ELISA Ready-
Set-Go Reagent Kit (eBiosciences) according to the manufacturer’s
instructions.
Real-time reverse transcriptase–PCR
Total RNA was harvested by means of the RNAeasy Isolation Kit
(Qiagen, Valencia, CA). Total RNA quality was determined with a
Bioanalyzer (Agilent, Cold Spring, NY). Reverse transcriptase–PCR
was performed using SYBR green mastermix (Agilent). All primer
sequences are listed in Supplementary Table S2 online.
Statistical analysis
For the two-group comparisons, statistical differences were deter-
mined by means of the unpaired two-tailed t-test. Multiple sample
comparisons were made using one-way analysis of variance, with
Po0.05 indicating signiﬁcance. All values were calculated with
Excel (Microsoft, Redmond, WA), Sigmaplot (Systat Software, San
Jose, CA), and Prism software (GraphPad, La Jolla, CA).
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